Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports First Quarter 2023 Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
PhaseOne Health Collaborates with Nonprofit Humanitarian Organization to Supply NovaBay Pharmaceuticals’ Phase One® Skin and Wound Cleanser to Ukraine
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Fulfills $1 Million Order for NeutroPhase® Skin and Wound Cleanser for China Pioneer Pharma Holdings
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces $3.0 Million Convertible Note Financing
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Launches DERMAdoctor’s New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals’ Avenova.com and Physician-Dispensed Channel
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
PhaseOne Health and NovaBay Pharmaceuticals to Expand Commercial and Collaborative Strategies for the Wound Care Market
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers NBY
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.